Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

Open Access 01-12-2020 | Bronchoscopy | Case report

Haemoptysis as the first presentation of COVID-19: a case report

Authors: Elise Peys, Dieter Stevens, Yannick Vande Weygaerde, Thomas Malfait, Laurens Hermie, Philippe Rogiers, Pieter Depuydt, Eva Van Braeckel

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that profoundly challenges healthcare systems all over the world. Fever, cough and fatigue are the most commonly reported clinical symptoms.

Case presentation

A 58-year-old man presented at the emergency department with acute onset haemoptysis. On the fifth day after admission, he developed massive haemoptysis. Computed tomography (CT) angiography of the chest revealed alveolar haemorrhage, more prominent in the left lung. Flexible bronchoscopy confirmed bleeding from the left upper lobe, confirmed by a bronchial arteriography, which was successfully embolized. Nasopharyngeal swabs (NPS) tested for SARS-CoV-2 using real-time polymerase chain reaction (RT-PCR) repeatedly returned negative. Surprisingly, SARS-CoV-2 was eventually detected in bronchoalveolar lavage (BAL) fluid.

Conclusions

Life-threatening haemoptysis is an unusual presentation of COVID-19, reflecting alveolar bleeding as a rare but possible complication. This case emphasises the added value of bronchoscopy with BAL in the diagnostic work-up in case of high clinical suspicion and negative serial NPS in patients presenting with severe symptoms.
Literature
1.
go back to reference Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRef Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRef
2.
go back to reference Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Inf Secur. 2020;80(6):656–65. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Inf Secur. 2020;80(6):656–65.
3.
go back to reference Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32(4):1131–2.CrossRef Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32(4):1131–2.CrossRef
4.
go back to reference Davidson K, Shojaee S. Managing massive hemoptysis. Chest. 2020;157(1):77–88.CrossRef Davidson K, Shojaee S. Managing massive hemoptysis. Chest. 2020;157(1):77–88.CrossRef
6.
go back to reference Lal A, Mishra AK, Sahu KK. Is EVALI the new scapegoat for every abnormal chest imaging? Heart Lung. 2020;49(4):437.CrossRef Lal A, Mishra AK, Sahu KK. Is EVALI the new scapegoat for every abnormal chest imaging? Heart Lung. 2020;49(4):437.CrossRef
7.
go back to reference Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features. Korean J Radiol. 2020;21(5):537–40.CrossRef Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features. Korean J Radiol. 2020;21(5):537–40.CrossRef
10.
go back to reference von Ranke FM, Zanetti G, Hochhegger B, Marchiori E. Infectious diseases causing diffuse alveolar hemorrhage in Immunocompetent patients: a state-of-the-art review. Lung. 2013;191(1):9–18.CrossRef von Ranke FM, Zanetti G, Hochhegger B, Marchiori E. Infectious diseases causing diffuse alveolar hemorrhage in Immunocompetent patients: a state-of-the-art review. Lung. 2013;191(1):9–18.CrossRef
11.
go back to reference Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–4.PubMedPubMedCentral Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–4.PubMedPubMedCentral
13.
go back to reference Malfait T, De Clercq J, Vandekerckhove L, Boelens J, Vandendriessche S, Coorevits L, Verhasselt B, Padalko E, Malfait S, Hertegonne K, Bauters F, Stevens D, Vande Weygaerde Y, Van Biesen W, Vanommeslaeghe F, Verbeke F, Vermaelen K, Van Braeckel E. The role of bronchoscopy in COVID-19 patients during the SARS-CoV-2 pandemic. Late breaking abstract presented at ERS Conference; 2020. Malfait T, De Clercq J, Vandekerckhove L, Boelens J, Vandendriessche S, Coorevits L, Verhasselt B, Padalko E, Malfait S, Hertegonne K, Bauters F, Stevens D, Vande Weygaerde Y, Van Biesen W, Vanommeslaeghe F, Verbeke F, Vermaelen K, Van Braeckel E. The role of bronchoscopy in COVID-19 patients during the SARS-CoV-2 pandemic. Late breaking abstract presented at ERS Conference; 2020.
Metadata
Title
Haemoptysis as the first presentation of COVID-19: a case report
Authors
Elise Peys
Dieter Stevens
Yannick Vande Weygaerde
Thomas Malfait
Laurens Hermie
Philippe Rogiers
Pieter Depuydt
Eva Van Braeckel
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01312-6

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue